Subscribe To Our Free Newsletter |
Piramal Pharma zooms over 10% on strong Q4 earnings; CDMO biz gives boost
In Q4FY24, Piramal Pharma reported a 102 per cent Year-on-Year (YoY) surge in Profit After Tax (PAT), totaling Rs 101.27 crore